Biopharmaceutics

Biography

Alex Nivorozhkin is an Entrepreneur and a Team builder in life sciences’ arena with vast experience and track record in an early technology transfer and development. He was a Co-founding Member of Boston BioCom, LLC, a biopharma company funded by the seed investment from Pfizer, Neo-Advent Technologies LLC, Amorsa Therapeutics, an emerging company developing new medications and formulation approaches for treatment of the refractory pain, and other ventures. He gained substantial experience in the commercial aspects of drug discovery and development at Epix Medical and Inotek Pharmaceuticals where he served as the company’s Head of Medicinal Chemistry. He was as a Senior Program Manager at the Center of Integration of Medicine and Innovative Technologies (CIMIT) at Massachusetts General Hospital, Draper Laboratory and MIT aimed at developing new medical devices; and a Scientific Programs Officer at Sheldon and Miriam Adelson Medical Research Foundation. He is a Co-inventor of several drug candidates that have advanced to clinical trials and late pre-clinical studies in the United States, has co-authored over 60 scientific publications in different areas of chemistry, chemical biology, and material sciences and holds more than 20 patents. He received a PhD in Physical Organic Chemistry from Rostov University and conducted the Postdoctoral research at the University Paris-Sud, France, and the Department of Chemistry and Chemical Biology, Harvard University. He is a Member of the American Chemical Society, Controlled Release Society, American Association of the Pharmaceutical Sciences and other professional organizations, active on the conference circle and serves as a co-chair of the Formulation and Drug Delivery Committee of the Massachusetts Biotechnology Council.

Abstract

Abstract : Tamper-resistant drug formulations - How effective they really are?